Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Bone Marrow Cells Can Travel After Transplantation

By Biotechdaily staff writers
Posted on 17 Feb 2003
A study has found that some bone marrow cells transplanted after high-dose chemotherapy are able to relocate to other tissues throughout the body rather than being restricted to the bone marrow and blood. More...
This information was published February 7, 2003, in the online edition of the Proceedings of the National Academy of Sciences.

Investigators from the Stanford University School of Medicine (Stanford, CA, USA) studied brain samples taken from women who were treated for leukemia with chemotherapy and then later received bone marrow transplants from male donors. These samples were ideal for this study because the donor cells contained a Y sex chromosome whereas cells in the women contained only X chromosomes.

Blood cells taken from the brains of the leukemia patients after death contained Y chromosomes, since bone marrow cells from the transplant generated them. However, five nerve cells (Purkinje cells) involved in controlling balance and movement were found to contain Y chromosomes in addition to their original X chromosomes. These out-of-place chromosomes could only have come from male cells in the bone marrow transplant. The study demonstrated that although Purkinje neurons are no longer generated after birth, cells within the bone marrow could contribute to these central system neurons even in adulthood.

Dr. Helen Blau, senior author and professor of pharmacology at the Stanford University School of Medicine, explained that the Purkinje cells may have gotten their Y chromosome from a group of traveling bone marrow cells. "I think these cells may act as a repair squad. The cells travel the bloodstream, respond to stress, and repair damaged tissues such as brain, muscle, and possibly others throughout the body,” said Dr. Blau.”



Related Links:
Stanford University Medical Center

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.